Circulating citrulline levels: a biomarker for intestinal functionality assessment

被引:17
作者
Crenn, Pascal [1 ,2 ]
Hanachi, Mouna [1 ,2 ]
Neveux, Nathalie [2 ,3 ,4 ]
Cynober, Luc [2 ,3 ,4 ]
机构
[1] Univ Versailles St Quentin En Yvelines, Hop Raymond Poincare, Assistance Publ Hop Paris, Dept Med Aigue Specialisee,EA 4497, Garches, France
[2] Univ Paris 05, Fac Pharm, EA 4466, Paris, France
[3] Hop Cochin, Assistance Publ Hop Paris, F-75674 Paris, France
[4] Hop Hotel Dieu, Serv Interhosp Biochim, Paris, France
关键词
citrulline; enterocytes; intestine; intestinal failure; SHORT-BOWEL SYNDROME; BLOOD SPOT CITRULLINE; PLASMA CITRULLINE; ENTEROCYTE MASS; SERUM CITRULLINE; MYELOABLATIVE THERAPY; PARENTERAL-NUTRITION; PROTEIN-METABOLISM; EPITHELIAL DAMAGE; VILLOUS ATROPHY;
D O I
10.1684/abc.2011.0609
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Circulating citrulline is emerging as an innovating biomarker candidate for assessment of intestinal function. Amino acid synthesized by enterocytes of intestinal mucosal, citrulline is not included in proteins or nutrition products and is a precursor for production of arginine by the kidney. Plasma citrulline is, in clinical situation, an established biomarker of enterocyte functional metabolic mass (trophicity) in children and in adult patients due to its high relation to active functional small bowel remnant length in intestinal diseases (short bowel, extensive enteropathies, intestinal toxicity of chemotherapy and radiotherapy. Plasma citrulline concentration (30-50 mu mol/L), independent of nutritional status, if less than 10 mu mol/L can give an objective threshold for nutrition parenteral use in case of intestinal failure due to enterocyte abnormalities or lack. Its regular dosage allows the monitoring of intestinal function except in case of significant renal failure.
引用
收藏
页码:513 / 521
页数:9
相关论文
共 54 条
[1]   Plasma Citrulline Concentration Reflects Enterocyte Mass in Children With Short Bowel Syndrome [J].
Bailly-Botuha, Celine ;
Colomb, Virginie ;
Thioulouse, Elizabeth ;
Berthe, Marie-Clotilde ;
Garcette, Karine ;
Dubern, Beatrice ;
Goulet, Olivier ;
Couderc, Remy ;
Girardet, Jean-Philippe .
PEDIATRIC RESEARCH, 2009, 65 (05) :559-563
[2]   Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy [J].
Blijlevens, NMA ;
Lutgens, LCHW ;
Schattenberg, AVMB ;
Donnelly, JP .
BONE MARROW TRANSPLANTATION, 2004, 34 (03) :193-196
[3]   Teduglutide, a Novel Mucosally Active Analog of Glucagon-Like Peptide-2 (GLP-2) for the Treatment of Moderate to Severe Crohn's Disease [J].
Buchman, Alan L. ;
Katz, Seymour ;
Fang, John C. ;
Bernstein, Charles N. ;
Abou-Assi, Souheil G. .
INFLAMMATORY BOWEL DISEASES, 2010, 16 (06) :962-973
[4]   PLASMA ARGININE, CITRULLINE, AND ORNITHINE KINETICS IN ADULTS, WITH OBSERVATIONS ON NITRIC-OXIDE SYNTHESIS [J].
CASTILLO, L ;
SANCHEZ, M ;
VOGT, J ;
CHAPMAN, TE ;
DEROJASWALKER, TC ;
TANNENBAUM, SR ;
AJAMI, AM ;
YOUNG, VR .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 268 (02) :E360-E367
[5]   Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans [J].
Crenn, P ;
Coudray-Lucas, C ;
Thuillier, F ;
Cynober, L ;
Messing, B .
GASTROENTEROLOGY, 2000, 119 (06) :1496-1505
[6]   Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease [J].
Crenn, P ;
Vahedi, K ;
Lavergne-Slove, A ;
Cynober, L ;
Matuchansky, C ;
Messing, B .
GASTROENTEROLOGY, 2003, 124 (05) :1210-1219
[7]  
Crenn P, 2001, Rev Prat, V51, P977
[8]   Post-absorptive plasma citrulline concentration: A marker of intestinal failure in humans [J].
Crenn, P ;
Coudray-Lucas, C ;
Cynober, L ;
Messing, B .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (06) :2528-2528
[9]   Clinical and biochemical modelization of postsurgical intestinal failure in human adults [J].
Crenn, P ;
Matuchansky, C ;
Messing, B .
CLINICAL NUTRITION, 1997, 16 (03) :133-135
[10]  
Crenn P, 2010, CLIN NUTR, V5, P214